BioAtla, Inc. (BCAB)
NASDAQ: BCAB · Real-Time Price · USD
0.4510
-0.0053 (-1.16%)
Apr 25, 2025, 11:26 AM EDT - Market open
BioAtla Market Cap
BioAtla has a market cap or net worth of $26.34 million as of April 25, 2025. Its market cap has decreased by -84.66% in one year.
Market Cap
26.34M
Enterprise Value
-21.45M
1-Year Change
-84.66%
Ranking
Category
Stock Price
$0.45
Market Cap Chart
Since the IPO on December 16, 2020, BioAtla's market cap has decreased from $577.60M to $26.34M, a decrease of -95.44%. That is a compound annual growth rate of -50.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 24, 2025 | 26.65M | -22.32% |
| Dec 31, 2024 | 34.30M | -70.91% |
| Dec 29, 2023 | 117.92M | -69.81% |
| Dec 30, 2022 | 390.66M | -45.97% |
| Dec 31, 2021 | 723.09M | -36.84% |
| Dec 31, 2020 | 1.14B | 98.22% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 777.71B |
| UnitedHealth Group | 376.32B |
| Johnson & Johnson | 369.72B |
| AbbVie | 323.35B |
| Novo Nordisk | 276.96B |
| Abbott Laboratories | 222.05B |
| AstraZeneca | 215.41B |
| Novartis AG | 210.89B |